Details

Autor(en) / Beteiligte

• Gomi, Harumi
• Solomkin, Joseph S.
• Schlossberg, David
• Okamoto, Kohji
• Takada, Tadahiro
• Strasberg, Steven M.
• Ukai, Tomohiko
• Endo, Itaru
• Iwashita, Yukio
• Hibi, Taizo
• Pitt, Henry A.
• Matsunaga, Naohisa
• Takamori, Yoriyuki
• Umezawa, Akiko
• Asai, Koji
• Suzuki, Kenji
• Han, Ho‐Seong
• Hwang, Tsann‐Long
• Mori, Yasuhisa
• Yoon, Yoo‐Seok
• Huang, Wayne Shih‐Wei
• Belli, Giulio
• Dervenis, Christos
• Yokoe, Masamichi
• Kiriyama, Seiki
• Itoi, Takao
• Jagannath, Palepu
• Garden, O. James
• Miura, Fumihiko
• Santibañes, Eduardo
• Shikata, Satoru
• Noguchi, Yoshinori
• Wada, Keita
• Honda, Goro
• Supe, Avinash Nivritti
• Yoshida, Masahiro
• Mayumi, Toshihiko
• Gouma, Dirk J.
• Deziel, Daniel J.
• Liau, Kui‐Hin
• Chen, Miin‐Fu
• Liu, Keng‐Hao
• Su, Cheng‐Hsi
• Chan, Angus C. W.
• Yoon, Dong‐Sup
• Choi, In‐Seok
• Jonas, Eduard
• Chen, Xiao‐Ping
• Fan, Sheung Tat
• Ker, Chen‐Guo
• Giménez, Mariano Eduardo
• Kitano, Seigo
• Inomata, Masafumi
• Mukai, Shuntaro
• Higuchi, Ryota
• Hirata, Koichi
• Inui, Kazuo
• Sumiyama, Yoshinobu
• Yamamoto, Masakazu

Titel

Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis

Ist Teil von

• Journal of hepato-biliary-pancreatic sciences, 2018-01, Vol.25 (1), p.3-16

Ort / Verlag

Japan: Wiley Subscription Services, Inc

Erscheinungsjahr

2018

Quelle

Wiley Online Library Journals Frontfile Complete

Beschreibungen/Notizen

• Antimicrobial therapy is a mainstay of the management for patients with acute cholangitis and/or cholecystitis. The Tokyo Guidelines 2018 (TG18) provides recommendations for the appropriate use of antimicrobials for community‐acquired and healthcare‐associated infections. The listed agents are for empirical therapy provided before the infecting isolates are identified. Antimicrobial agents are listed by class‐definitions and TG18 severity grade I, II, and III subcategorized by clinical settings. In the era of emerging and increasing antimicrobial resistance, monitoring and updating local antibiograms is underscored. Prudent antimicrobial usage and early de‐escalation or termination of antimicrobial therapy are now important parts of decision‐making. What is new in TG18 is that the duration of antimicrobial therapy for both acute cholangitis and cholecystitis is systematically reviewed. Prophylactic antimicrobial usage for elective endoscopic retrograde cholangiopancreatography is no longer recommended and the section was deleted in TG18. Free full articles and mobile app of TG18 are available at: http://www.jshbps.jp/modules/en/index.php?content_id=47. Related clinical questions and references are also included. Highlight Following a systematic review of the TG13 and consensus by the Tokyo Guidelines Revision Committee, Gomi and colleagues provide recommendations for antimicrobial agents for community‐acquired and healthcare‐associated acute cholangitis and cholecystitis. New in the TG18 is a systematic review of the duration of antimicrobial therapy for both cholangitis and cholecystitis.